HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Fujii Selected Research

Plasminogen Inactivators

11/2012Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells.
12/2011Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by cAMP in HepG2 liver cells.
11/2011Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
8/2007Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants.
3/2007Elevated plasma plasminogen activator inhibitor type-1 is an independent predictor of coronary microvascular dysfunction in hypertension.
10/2006Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
3/2005Loss of insulin receptor substrate-1 signaling induces the cardiovascular and proteo(fibrino)lytic system derangements typical of insulin resistance.
8/2004Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
4/2004Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Fujii Research Topics

Disease

75Neoplasms (Cancer)
10/2022 - 03/2003
16Neoplasm Metastasis (Metastasis)
11/2022 - 02/2008
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2007
15Atherosclerosis
03/2016 - 03/2002
12Esophageal Squamous Cell Carcinoma
11/2022 - 01/2015
10Breast Neoplasms (Breast Cancer)
01/2021 - 08/2003
9Hypertension (High Blood Pressure)
05/2020 - 05/2002
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2019 - 11/2008
8Insulin Resistance
01/2016 - 08/2004
7Inflammation (Inflammations)
07/2022 - 05/2002
7Infections
01/2022 - 06/2007
7Stomach Neoplasms (Stomach Cancer)
10/2021 - 04/2008
7Lung Neoplasms (Lung Cancer)
10/2020 - 06/2007
7Coronary Artery Disease (Coronary Atherosclerosis)
03/2016 - 06/2007
6Hypoxia (Hypoxemia)
07/2022 - 12/2013
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 03/2003
6Carcinoma (Carcinomatosis)
02/2019 - 06/2010
5Esophageal Neoplasms (Esophageal Cancer)
11/2022 - 02/2016
5Lymphatic Metastasis
11/2022 - 01/2007
5Adenocarcinoma
01/2020 - 01/2016
5Adenocarcinoma of Lung
12/2018 - 01/2016
5Pressure Ulcer (Bedsore)
11/2018 - 05/2009
5Rectal Neoplasms (Rectal Cancer)
12/2016 - 11/2011
5Hepatocellular Carcinoma (Hepatoma)
06/2013 - 09/2003
4Wounds and Injuries (Trauma)
11/2018 - 07/2010
4Tetanus
05/2016 - 05/2008
4Squamous Cell Carcinoma of Head and Neck
03/2016 - 11/2012
4Obesity
01/2016 - 08/2004
4Thrombosis (Thrombus)
12/2014 - 06/2003
4Type 2 Diabetes Mellitus (MODY)
11/2011 - 03/2005
4Fibrosis (Cirrhosis)
11/2011 - 08/2004
3COVID-19
07/2022 - 01/2021
3Neutropenia
01/2022 - 02/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 01/2016
3Body Weight (Weight, Body)
01/2016 - 02/2010
3Myocardial Infarction
11/2011 - 08/2007
2Virus Diseases (Viral Diseases)
11/2021 - 10/2003
2Hemorrhage
10/2021 - 08/2007

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2008
12Biological ProductsIBA
07/2019 - 06/2007
12Plasminogen Activator Inhibitor 1IBA
12/2013 - 09/2003
9Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2010
9Plasminogen InactivatorsIBA
11/2012 - 04/2004
7Trastuzumab (Herceptin)FDA Link
11/2021 - 05/2011
7Cadherins (E-Cadherin)IBA
01/2021 - 04/2008
6ParaffinIBA
01/2022 - 11/2012
6ezrinIBA
01/2018 - 01/2016
5Formaldehyde (Formol)FDA Link
01/2022 - 06/2013
5Carbonic Anhydrase IXIBA
01/2021 - 04/2013
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 09/2003
5KalininIBA
07/2019 - 04/2013
5Indicators and Reagents (Reagents)IBA
02/2019 - 08/2003
5Histones (Histone)IBA
01/2012 - 03/2003
4Oxygen (Dioxygen)IBA
07/2022 - 09/2008
4Docetaxel (Taxotere)FDA Link
01/2022 - 02/2008
4RNA (Ribonucleic Acid)IBA
12/2021 - 01/2016
4MicroRNAs (MicroRNA)IBA
12/2021 - 01/2016
4human ERBB2 proteinIBA
11/2021 - 01/2014
4CytokinesIBA
01/2021 - 09/2003
4dihydroceramide desaturaseIBA
10/2020 - 01/2016
4Messenger RNA (mRNA)IBA
01/2020 - 03/2005
4Small Interfering RNA (siRNA)IBA
01/2020 - 04/2008
4Ointments (Pastes)IBA
11/2018 - 07/2010
4IodineIBA
01/2014 - 05/2009
4Apolipoproteins E (ApoE)IBA
04/2013 - 03/2002
4Glucose (Dextrose)FDA LinkGeneric
04/2012 - 03/2007
3Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 01/2007
3Pharmaceutical PreparationsIBA
02/2021 - 05/2011
3Epidermal Growth Factor (EGF)IBA
01/2021 - 12/2012
3Monoclonal AntibodiesIBA
01/2021 - 11/2017
3DNA (Deoxyribonucleic Acid)IBA
12/2020 - 09/2018
3SphingolipidsIBA
10/2020 - 05/2015
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 08/2004
3Cetuximab (Erbitux)FDA Link
01/2020 - 12/2012
3AntibodiesIBA
05/2019 - 12/2012
3GemininIBA
02/2019 - 06/2010
3Hyaluronic Acid (Hyaluronan)IBA
11/2018 - 02/2015
3SphingosineIBA
08/2016 - 12/2013
3LigandsIBA
07/2016 - 05/2011
3HDL CholesterolIBA
01/2016 - 03/2007
3Codon (Codons)IBA
09/2013 - 12/2012
3ApolipoproteinsIBA
04/2013 - 03/2002
3AcidsIBA
01/2011 - 09/2003
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2010 - 09/2003
3ChromatinIBA
06/2008 - 03/2003
3Plasminogen Activators (Plasminogen Activator)IBA
01/2007 - 06/2003
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2020
2TeicoplaninIBA
01/2022 - 06/2021
2Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2007
2Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 01/2020
2VancomycinFDA LinkGeneric
12/2021 - 01/2013
2Circulating Tumor DNAIBA
11/2021 - 10/2021

Therapy/Procedure

22Therapeutics
01/2022 - 01/2013
15Drug Therapy (Chemotherapy)
01/2022 - 02/2008
11Chemoradiotherapy
11/2022 - 11/2011
8Neoadjuvant Therapy
01/2021 - 01/2013
5Radiotherapy
11/2022 - 02/2008
2Neck Dissection (Radical Neck Dissection)
10/2022 - 06/2016
2Precision Medicine
01/2022 - 01/2019
2Molecular Targeted Therapy
01/2022 - 02/2015